
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-06-07-2016
- Volume 11
- Issue 6
Patheon Appoints Michel Lagarde President
Lagarde will be based out of the company’s Boston office and will lead Patheon’s global corporate and cross-enterprise operations.
On May 31, 2016, Patheon
Lagarde joins Patheon from JLL Partners, a middle market private equity firm. For the past eight years, he has been working with several of JLL’s portfolio companies, including Patheon, in the healthcare and pharma services sectors as managing director. He has served as a member of Patheon’s Board of Directors since 2011. As a result of his appointment, Lagarde has stepped down from his position on Patheon’s Board of Directors.
Source:
Articles in this issue
over 9 years ago
Slow Serialization Efforts May Delay Business Benefitsover 9 years ago
Scientific Approach Ensures Accurate Weighing Resultsover 9 years ago
Ensuring Biologic API Uniformityover 9 years ago
Biomanufacturing Outsourcing Budgets Grow, Slowlyover 9 years ago
Novasep Starts Kilogram-Scale Batch Production at US Facilityover 9 years ago
FUJIFILM Opens New Laboratory in North Carolinaover 9 years ago
Catalent Opens Korean Sales Officeover 9 years ago
Juniper Pharma Services Expands Topicals Capacityover 9 years ago
ED-XRF Spectrometers Offer Rapid Elemental Analysisover 9 years ago
Raman Microscope Measures Uneven SurfacesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





